New York State Common Retirement Fund
SNDX icon

New York State Common Retirement Fund’s Syndax Pharmaceuticals SNDX Stock Holding History

New York State Common Retirement Fund’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$684K Buy
31,284
+5,900
+23% +$123K ﹤0.01% 1886
2026
Q1 		$593K Hold
25,384
– – ﹤0.01% 1847
2025
Q4 		$533K Hold
25,384
– – ﹤0.01% 1942
2025
Q3 		$391K Hold
25,384
– – ﹤0.01% 2036
2025
Q2 		$238K Hold
25,384
– – ﹤0.01% 2185
2025
Q1 		$312K Hold
25,384
– – ﹤0.01% 2055
2024
Q4 		$336K Hold
25,384
– – ﹤0.01% 2089
2024
Q3 		$489K Sell
25,384
-19,714
-44% -$407K ﹤0.01% 1948
2024
Q2 		$926K Sell
45,098
-2,477
-5% -$51.8K ﹤0.01% 1798
2024
Q1 		$1.13M Buy
47,575
+18,592
+64% +$415K ﹤0.01% 1717
2023
Q4 		$626K Sell
28,983
-1,842
-6% -$28.3K ﹤0.01% 2006
2023
Q3 		$448K Buy
30,825
+1,080
+4% +$20.4K ﹤0.01% 2104
2023
Q2 		$623K Buy
29,745
+60
+0.2% +$1.25K ﹤0.01% 1976
2023
Q1 		$627K Sell
29,685
-7,689
-21% -$191K ﹤0.01% 2064
2022
Q4 		$951K Buy
37,374
+12
+0% +$280 ﹤0.01% 2001
2022
Q3 		$898K Buy
37,362
+2,214
+6% +$49.7K ﹤0.01% 2029
2022
Q2 		$676K Buy
35,148
+2,754
+9% +$45.9K ﹤0.01% 2210
2022
Q1 		$563K Buy
32,394
+23
+0.1% +$387 ﹤0.01% 2354
2021
Q4 		$709K Sell
32,371
-94
-0.3% -$1.74K ﹤0.01% 2255
2021
Q3 		$620K Sell
32,465
-6,286
-16% -$105K ﹤0.01% 2350
2021
Q2 		$665K Buy
38,751
+14,051
+57% +$257K ﹤0.01% 2440
2021
Q1 		$552K Hold
24,700
– – ﹤0.01% 2402
2020
Q4 		$549K Hold
24,700
– – ﹤0.01% 2309
2020
Q3 		$365K Hold
24,700
– – ﹤0.01% 2367
2020
Q2 		$366K Buy
24,700
+6,600
+36% +$101K ﹤0.01% 2371
2020
Q1 		$199K Hold
18,100
– – ﹤0.01% 2460
2019
Q4 		$159K Sell
18,100
-2,400
-12% -$17.6K ﹤0.01% 2834
2019
Q3 		$153K Hold
20,500
– – ﹤0.01% 2889
2019
Q2 		$191K Buy
20,500
+11,100
+118% +$80.9K ﹤0.01% 2839
2019
Q1 		$49K Hold
9,400
– – ﹤0.01% 3071
2018
Q4 		$42K Hold
9,400
– – ﹤0.01% 3104
2018
Q3 		$76K Hold
9,400
– – ﹤0.01% 3079
2018
Q2 		$66K Hold
9,400
– – ﹤0.01% 3127
2018
Q1 		$134K Hold
9,400
– – ﹤0.01% 2877
2017
Q4 		$82K Hold
9,400
– – ﹤0.01% 3004
2017
Q3 		$110K Hold
9,400
– – ﹤0.01% 2985
2017
Q2 		$131K Buy
9,400
+7,599
+422% +$86.9K ﹤0.01% 3030
2017
Q1 		$25K Buy
1,801
+1
+0.1% +$10 ﹤0.01% 3107
2016
Q4 		$13K Hold
1,800
– – ﹤0.01% 3111
2016
Q3 		$27K Sell
1,800
-9,300
-84% -$122K ﹤0.01% 3110
2016
Q2 		$109K Buy
+11,100
New +$152K ﹤0.01% 2959

Other funds holding SNDX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VIG
Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

New York State Common Retirement Fund's SNDX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Syndax Pharmaceuticals (SNDX) stake by 23% in Q2 2026, buying an estimated $123K and bringing the position to 31,284 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

New York State Common Retirement Fund first reported a position in SNDX in Q2 2016 and has held it in 41 quarters since. The position peaked at $1.13M in Q1 2024. 49 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • New York State Common Retirement Fund held 31,284 shares of Syndax Pharmaceuticals worth $684K as of Q2 2026.
  • New York State Common Retirement Fund bought 5,900 Syndax Pharmaceuticals shares in Q2 2026, an estimated $123K.
  • Syndax Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1886 holding.
  • New York State Common Retirement Fund first reported a position in Syndax Pharmaceuticals in Q2 2016 and has held it in 41 quarters since.
  • New York State Common Retirement Fund's Syndax Pharmaceuticals position peaked at $1.13M in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.